Insider · CIK 0001713712

Flynn Daniel Lee

Reports to the SEC for 1 company · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001713712

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,655 sh	$14.40	−$23.8K	57,158
2023-02-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,370 sh	$15.10	−$20.7K	58,813
2023-02-15	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+65.9K sh	—	—	65,900
2023-02-15	Deciphera Pharmaceuticals, Inc.A Award	Chief Scientific Officer	AAward	+16.5K sh	—	—	60,183
2023-01-17	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−2,403 sh	$21.24	−$51K	43,695
2022-06-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,768 sh	$10.75	−$19K	46,098
2022-02-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,366 sh	$9.05	−$12.4K	47,866
2022-01-18	Deciphera Pharmaceuticals, Inc.A Award	Chief Scientific Officer	AAward	+20.5K sh	—	—	49,232
2022-01-18	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+82K sh	—	—	82,000
2021-12-15	Deciphera Pharmaceuticals, Inc.A Award	Chief Scientific Officer	AAward	+11.1K sh	—	—	28,732
2021-12-15	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+82.3K sh	—	—	82,265
2021-02-16	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+49.9K sh	—	—	49,900
2021-02-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−508 sh	$48.87	−$24.8K	6,532
2021-02-16	Deciphera Pharmaceuticals, Inc.A Award	Chief Scientific Officer	AAward	+11.1K sh	—	—	17,632
2020-08-10	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+9,029 sh	$1.89	+$17.1K	237,475
2020-08-10	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−9,029 sh	—	—	0
2020-07-22	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+130K sh	$1.89	+$246K	228,446
2020-07-22	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−130K sh	—	—	9,029
2020-02-18	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	−42.2K sh	—	—	42,190
2020-02-18	Deciphera Pharmaceuticals, Inc.A Award	Chief Scientific Officer	AAward	+7,040 sh	—	—	98,446
2020-01-16	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10.1K sh	—	—	29,444
2020-01-16	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10.1K sh	$3.95	+$39.9K	34,606
2020-01-16	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+56.8K sh	$6.13	+$348K	91,406
2020-01-16	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−56.8K sh	—	—	94,817
2020-01-16	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10.1K sh	—	—	4,944
2019-12-12	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−31K sh	$60.00	−$1.86M	35,750
2019-12-10	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+28.8K sh	$1.89	+$54.5K	53,322
2019-12-10	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−28.8K sh	—	—	107,827
2019-12-10	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−93.9K sh	$55.00	−$5.17M	24,500
2019-12-10	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+93.9K sh	$1.89	+$178K	118,430
2019-12-10	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−28.8K sh	$55.00	−$1.59M	24,500
2019-12-10	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−93.9K sh	—	—	13,897
2019-12-09	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−30.2K sh	—	—	136,649
2019-12-09	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+30.2K sh	$1.89	+$57K	54,675
2019-12-09	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−30.2K sh	$55.00	−$1.66M	24,500
2019-11-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−143K sh	—	—	166,824
2019-11-11	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−143K sh	$48.01	−$6.87M	24,500
2019-11-11	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+143K sh	$1.89	+$271K	167,685
2019-11-08	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−9,742 sh	—	—	310,009
2019-11-08	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+9,742 sh	$1.89	+$18.4K	34,242
2019-11-08	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−9,742 sh	$48.00	−$468K	24,500
2019-10-28	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+29.8K sh	$1.89	+$56.4K	54,320
2019-10-28	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−29.8K sh	—	—	319,751
2019-10-28	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−29.8K sh	$40.00	−$1.19M	24,500
2019-08-13	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−123K sh	—	—	349,571
2019-08-13	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−25K sh	$42.90	−$1.07M	66,779
2019-08-13	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+123K sh	$1.89	+$233K	147,607
2019-08-13	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−29.7K sh	$41.33	−$1.23M	24,500
2019-08-13	Deciphera Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−93.4K sh	$40.26	−$3.76M	54,212
2019-02-21	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+24.5K sh	$3.95	+$96.8K	24,500

Recent filings

Accepted (ET)
Jun 214
Flynn Daniel Lee0001209191-23-038753
SEC(opens sec.gov)
Feb 174
Flynn Daniel Lee0001209191-23-010488
SEC(opens sec.gov)
Jan 194
Flynn Daniel Lee0001209191-23-004001
SEC(opens sec.gov)
Jun 214
Flynn Daniel Lee0001209191-22-038425
SEC(opens sec.gov)
Feb 184
Flynn Daniel Lee0001209191-22-011360
SEC(opens sec.gov)
Jan 204
Flynn Daniel Lee0001209191-22-004074
SEC(opens sec.gov)
Dec 174
Flynn Daniel Lee0001209191-21-070227
SEC(opens sec.gov)
Feb 184
Flynn Daniel Lee0001209191-21-012115
SEC(opens sec.gov)
Aug 124
Flynn Daniel Lee0001209191-20-046330
SEC(opens sec.gov)
Jul 244
Flynn Daniel Lee0001209191-20-043583
SEC(opens sec.gov)
Feb 204
Flynn Daniel Lee0001209191-20-011040
SEC(opens sec.gov)

Companies

Deciphera Pharmaceuticals, Inc.Chief Scientific Officer

Address

C/O DECIPHERA PHARMACEUTICALS, INC. 500 TOTTEN POND ROAD

WALTHAM, MA, 02451